Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3
- PMID: 15388479
- PMCID: PMC521926
- DOI: 10.1128/AAC.48.10.4054-4055.2004
Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3
Abstract
Resistance-nodulation-cell division type efflux pump AdeDE was identified in acinetobacters belonging to genomic DNA group 3. Inactivation of adeE showed that it may be responsible for reduced susceptibility to amikacin, ceftazidime, chloramphenicol, ciprofloxacin, erythromycin, ethidium bromide, meropenem, rifampin, and tetracycline. However, unlike what was found for other similar efflux systems, the open reading frame for the outer membrane component was not found downstream of the adeDE gene cluster.
References
-
- National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing. Informational supplement M100-S11. National Committee for Clinical Laboratory Standards, Wayne, Pa.
-
- Ng, T. K., J. M. Ling, A. F. B. Cheng, and S. R. Norrby. 1996. A retrospective study of clinical characteristics of Acinetobacter bacteremia. Scand. J. Infect. Dis. 101(Suppl.):26-32. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
